Delivery Order SPE2DB22D3004-SPE2DB25FRW80
- Not listed
- The Defense Logistics Agency awarded a $1,885.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Duramorph 5 mg/10 mL ampules on August 13, 2025, with completion targeted for August 14, 2025. This competitively awarded contract, which carries no set-aside designation, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Duramorph is a morphine sulfate injectable pharmaceutical product used for pain management in medical settings,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,251.88 to AmerisourceBergen Drug Corp for the supply of Duramorph 10 mg/10 mL ampules. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the vendor's pharmaceutical supply services to support federal...
- AmerisourceBergen Drug Corp was awarded a competitively procured delivery order valued at $3,648.30 for Duramorph 5 mg/10 mL ampules through the Defense Logistics Agency's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 8, 2025. This award represents a firm fixed-price delivery order with no set-aside designation, sourced to the vendor's corporate office located in Conshohocken, Pennsylvania. The pharmaceutical product will support federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,581.99 to AmerisourceBergen Drug Corp for Duramorph 5 mg/10 mL ampuls on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,786.10 from the Defense Logistics Agency Troop Support Medical to supply Duramorph 5 mg/10 ml ampules. As the prime contractor, Amerisourcebergen will deliver 10 ml ampules of the specified narcotic pain medication to support military treatment programs. This award was made against an indefinite delivery contract held by Amerisourcebergen with no set-aside designation used. Performance will occur at...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide DURAMORPH 5 MG/10 ML AMPUL 10ML pharmaceuticals. The contract has a potential value of $3,563.40 and a completion date of February 14, 2024. This delivery order contract is under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a specialty pharmaceutical product. The award, valued at $1,130.00, has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML medical products. The contract has a ceiling value of $2,249.67 and a completion date of May 2, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,094.67, is a delivery order for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $1,309.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4563943727 - DURAMORPH 5 MG/10 ML AMPUL 10ML. The contract is a firm fixed price delivery order with a performance period through March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRW80Delivery Order
The Defense Logistics Agency awarded a $1,150.31 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Duramorph 10 mg/10 mL ampuls. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), was competitively awarded without set-aside designation and carries an ultimate completion date of August 8, 2025. Performance will take place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Duramorph (morphine sulfate) is a critical pharmaceutical for pain management in military and federal healthcare systems. This delivery order represents a routine transaction under AmerisourceBergen's comprehensive $999.999 billion IDC with DLA, which runs through December 2026 and serves as a global pharmaceutical support vehicle for the Defense Health Agency and other federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal contracts covering a broad spectrum of medications and medical supplies across multiple therapeutic domains. The company's competitive awards and firm fixed pricing across numerous delivery orders demonstrate its established capability to meet federal medical procurement requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/7/25 |